Prof. Axel Ullrich: The New--Realistic--Biotech Era
Executive Summary
Perhaps Europe's leading academic entrepreneur, professor Axel Ullrich, PhD, joined Genentech in its infancy, then, returning to Germany as a director of the Max-Planck Institute, swam against a generally anti-commercial tide within the German academic community by founding Sugen and several German start-ups, most recently, U3 Pharma. He describes the aftermath of Germany's BioRegio program and a new dose of realism in European biotech.